news roundup
Please see the latest new hires and job changes, along with company milestone news.
| Advertisement Tell us what you think about clinical operations and receive a $5 Amazon gift card!
 TAKE THE SHORT SURVEY |
Departing FDA Commissioner Gottlieb welcomed newly-named Acting Commissioner Norman (Ned) Sharpless, currently Director of the National Cancer Institute (NCI) at the National Institutes of Health (NIH), who will start next month.
| Advertisement Technology: Friend vs Foe - Considerations for Practical Execution of a Risk-Based Monitoring Strategy
Tuesday, April 23, 2019 at 11am EDT | 10am CDT | 4pm BST | 5pm CEST
 Register now |
Envigo, a provider of non-clinical contract research services and research models, announced the launch of PATHWAY—an integrated solution that optimizes non-clinical safety assessment programs to enable first-in-human clinical trials.
| Advertisement RBM Case Studies: How Artificial Intelligence and Machine Learning with Advanced Analytics are driving new levels of patient safety and study quality
Thursday, March 28, 2019 at 11am EDT
 Register now |
Articles
Ken Getz MBA, Director of Sponsored Research at the Tufts CSDD and Chairman of CISCRP, outlines the many barriers to delivering plain language clinical trial results summaries to study volunteers and the reasons why it is not embraced by the clinical research enterprise.
| Advertisement
Fast, Focused Medical Data Review – Use Cases by a Medical Monitor
Wednesday, March 27, 2019 at 11am EDT| 8am PDT| 3pm GMT| 4pm CET
 Register now |
Regular contributor Moe Alsumidaie looks back over the coverage of patient centricity in Applied Clinical Trials to see how the initiative has progressed over the years.
|
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
Events
Blog Posts
As the industry moves to implement Risk-Based Everything (RBX)—a more holistic risk-based approach to quality management—targeted risk management, offers many benefits.
| Advertisement
Minimizing the Impact of Human Error, Subjectivity, and Labor Costs
The Application of Digital Pathology in Clinical Trials
Tuesday, March 19, 2019 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET
 Register now |
Richard Tsai, Vice President of Marketing, Inspire discusses the growing number of collaborations among industry, academia, government, non-profit foundations, and patient advocacy organizations, specifically in the rare disease area of drug discovery and development.
|
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
